Market Commentary And PGNX Chart Review For Tuesday June 3 2014 – Market Top Pattern + Gap Fills In this video, I go over $SPY, $QQQ, $IWM, $PGNX, $IDIX, and $TROV. I talk about the gap in the $SPY at…
Market Commentary And PGNX Chart Review For Monday, June 2 2014 – Baffling
Market Commentary And PGNX Chart Review For Monday, June 2 2014 – Baffling.In this video, I review $PGNX and try to reason why the stock did something I did not expect it to do. Sometimes, I form a poor thesis…
The IBB Likely To Move Higher Along With These Biotechs With Near Term Catalysts
Summary Today, we list four bio pharmaceutical companies with upcoming catalysts. Typically, under normal market conditions, their stocks normally see strong price appreciation. Just because a biotech has an upcoming catalyst event, it does not mean the event will have…
Video Market Commentary And Chart Reviews For Monday, June 2 2014 – ECB In Focus
Market Commentary And Chart Reviews For Monday, June 2 2014 – ECB In Focus. $IBB, $PGNX, $QQQ, $SPY, $OREX, $HALO reviewed. ECB meets on Wednesday. Rate cut expected along with minor credit easing. I do not expect any talk of…
Progenics Phase II Poster Data From Saturday At ASCO
PDF attached, download from link below – A Phase 2 Trial of Prostate Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC) in Taxane Treated Metastatic Castration Resistant Prostate Cancer mCRPC PSMA_-_ASCO_Poster_2014_-_FINAL_5-27-2014
Progenics (PGNX) Video Chart Review
In this video which will be on Investor’s hub later tonight, early tomorrow, I give a detailed explanation on why we believe $PGNX will be headed higher from its current level, possibly breaking over $4.61. As always, Premium subscribers get…
Progenics Pharma Poised For A Potential Price Increase Ahead Of June 11th Adcom
Summary Progenics is expecting a Food and Drug Administration (FDA) Advisory Committee meeting on June 11 – 12 to decide whether or not to recommend a Supplemental New Drug Application (sNDA). The Relistor sNDA is for a subcutaneous injection for…
Market Commentary For Wed May 28 -OREX Goes Well + Reason For Small Cap Sell Off
Market Commentary For Wed May 28 -OREX Goes Well + Reason For Small Cap Sell Off $OREX hit $6.50 today, so I’m happy about it hitting where I said it had a chance to today. The markets sold off (profit…
Updated With New Chart: Catalyst Trade Alert: We Bought $PGNX Target opinion = $4.50
Catalyst: Advisory Committee Reschedule Update Progenics shares have not been high on investors’ radars in recent months because the FDA had rescheduled the set Advisory Committee (Adcom) meeting, which was due earlier this year. The FDA gave no guidance on…
Market Wrap With Chart and Macro Review May 27 2014 – $IBB And $QQQ Break Upwards
Market Wrap With Chart and Macro Review May 27 2014 – $IBB And $QQQ Break Upwards. $OREX, $SPY, $IBB, $QQQ charts covered and explained in this video. Additionally, I offer some macro commentary on the markets, enjoy! Scott NOTE: I…
